Immuno-oncology agents continue to transform cancer treatment landscape: GlobalData
GlobalData’s latest report, "Thematic Research: Immuno-Oncology” explores the IO pipeline and identifies over 700 novel agents…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CAR T-cell therapies
Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat…
Abecma is a first-in-class BCMA-directed personalised immune cell therapy delivered as a one-time infusion for triple-class…
Bayer, Atara Biotherapeutics to partner for mesothelin-targeted CAR T-cell therapies
The agreement includes the development candidate ATA3271, an armored allogeneic T-cell immunotherapy, and an autologous version,…